Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
about
Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional studyEndocrine fibroblast growth factors 15/19 and 21: from feast to famineType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightEndocrine causes of nonalcoholic fatty liver diseaseResearch Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLDEndocrine FGFs: Evolution, Physiology, Pathophysiology, and PharmacotherapyStressed Liver and Muscle Call on Adipocytes with FGF21Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders.Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth FactorsBeneficial role of bitter melon supplementation in obesity and related complications in metabolic syndromeFibroblast growth factors in cardiovascular disease: The emerging role of FGF21FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizersThe Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.Non-invasive methods for the diagnosis of nonalcoholic fatty liver diseaseMycotoxin in the food supply chain-implications for public health program.Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines.ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress.Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies.Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet.Cellular mechanisms by which FGF21 improves insulin sensitivity in male miceFibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosisNonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesFibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.Fructose ingestion acutely stimulates circulating FGF21 levels in humans.Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop.FGF21 promotes endothelial cell angiogenesis through a dynamin-2 and Rab5 dependent pathway.Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patientsHigh plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjectsFibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes.Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient dietBiomarkers of insulin sensitivity and insulin resistance: Past, present and future.Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient dietsMinireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
P2860
Q21135215-B0461B6D-E6B7-4630-B0FF-F41F52388541Q24629260-B45FF0C5-BDE3-4340-8637-24130DFAEA9FQ26752583-20AB764F-1515-489D-8E88-2AA6ED9AAFC3Q26780254-E9F2029B-6C5B-4292-8CBC-98C3D6F0BFEAQ26781431-DED9943A-B324-417C-8670-163D51E666E1Q26781556-A07646D9-4BA3-496D-94BD-E50F917A354DQ27014973-6D7B7CC6-1C2B-4499-8CE4-A38902B3490BQ27686803-94458D0C-DCE7-490C-8095-30102D0D33FFQ28076863-9827D01C-353A-4A91-A55F-D923E330B784Q28081950-375EF028-A3AF-4290-82BB-D87534028F61Q28084197-C7FFC18F-6F34-416B-A663-41F75134BD17Q28570740-628485F5-04A3-43AD-9F27-633192C93A6EQ30234616-CF6DBB6E-99B5-451F-826C-928EE523A890Q30414504-C46EDF9F-1CB5-4329-B6AC-0BB63FBE2A97Q31135574-9DC2B640-5B8A-4916-BF31-2FBF079905CDQ33628222-3FF66A1D-D0F7-4E94-9AD6-FBA8F513CA04Q33681667-742F7190-9FFC-45C3-A960-74125579F1A2Q33749608-ED3C8AE0-A148-4327-A645-2958C86DCAA0Q33845489-CCA8AF8E-4002-41F8-A4D9-E1F22533648CQ33895173-346671AF-E680-4922-A0FB-77FEAEFE503EQ34302360-6336E215-61A7-43D7-9D84-163C6EB01E20Q34350772-900CC531-E25E-4661-B108-3FEA9F550C76Q34396839-FFA18918-DBAB-47EB-8E9E-AA2CD1C3CE9AQ34657286-928772D9-A473-4313-885D-8D3613BC41B9Q34674492-1049A90E-6723-4606-863A-14393E5EC8FCQ35020888-F2CF2F05-86DC-48D3-82CF-4E822B0AA975Q35040490-ADA294F1-7E78-4060-BA76-1DD03AC0CE0FQ35054990-7309194F-A2E2-4D91-8565-70CBD4375D57Q35171987-187615E4-41DF-4188-BC34-D6209214EF3BQ35176887-B6BB535A-D59A-46E5-836C-E58798DAD911Q35179850-B06993F7-AE7D-4861-B640-99461DC0CA2BQ35266374-9F8B8764-CA02-45C2-A8AE-2CB60BA3C2DEQ35613153-63CD0A6E-4ED0-4A48-861E-E4DB0F99EAF4Q35652813-AFA3B092-C349-4591-B557-286DF4C49028Q35726506-0D2A393A-742C-4B2F-8A09-8D86353CF6FAQ35762326-035287B2-5423-48CA-A913-9FEAB9AB84B4Q35784028-FD449AFD-290C-47A7-A0A4-F1E0FE3CD326Q35857788-1AD20559-DADF-42F0-8534-4151C2CBFFA7Q36061647-268BB64C-90E2-4CC3-BE60-50E12E9E7E8DQ36107291-DC52C345-87DA-478D-91E9-899B57542407
P2860
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Fibroblast growth factor 21 le ...... ted with hepatic triglyceride.
@en
Fibroblast growth factor 21 le ...... ted with hepatic triglyceride.
@nl
type
label
Fibroblast growth factor 21 le ...... ted with hepatic triglyceride.
@en
Fibroblast growth factor 21 le ...... ted with hepatic triglyceride.
@nl
prefLabel
Fibroblast growth factor 21 le ...... ted with hepatic triglyceride.
@en
Fibroblast growth factor 21 le ...... ted with hepatic triglyceride.
@nl
P2093
P1476
Fibroblast growth factor 21 le ...... ted with hepatic triglyceride.
@en
P2093
Huating Li
Huizhen Zhang
Kunsan Xiang
Qichen Fang
Weiping Jia
Xiaoping Pan
P304
P356
10.1016/J.JHEP.2010.05.018
P577
2010-07-17T00:00:00Z